BioMarin Pharmaceutical
BMRN
#1967
Rank
HK$81.85 B
Marketcap
HK$423.52
Share price
0.28%
Change (1 day)
-12.86%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: HK$81.85 Billion

As of May 2026 BioMarin Pharmaceutical has a market cap of HK$81.85 Billion. This makes BioMarin Pharmaceutical the world's 1967th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$81.85 B-8.66%
2025HK$89.61 B-9.46%
2024HK$98.96 B-30.23%
2023HK$141.84 B-5.61%
2022HK$150.27 B18.81%
2021HK$126.48 B2.49%
2020HK$123.40 B4.21%
2019HK$118.42 B-0.37%
2018HK$118.85 B-2.85%
2017HK$122.35 B10.74%
2016HK$110.48 B-15.76%
2015HK$131.15 B25.45%
2014HK$104.54 B33.58%
2013HK$78.26 B63.12%
2012HK$47.97 B57.32%
2011HK$30.49 B31.54%
2010HK$23.18 B57.46%
2009HK$14.72 B7.24%
2008HK$13.73 B-48.77%
2007HK$26.80 B129.25%
2006HK$11.69 B88.28%
2005HK$6.21 B93.89%
2004HK$3.20 B-17%
2003HK$3.85 B30.51%
2002HK$2.95 B-46.16%
2001HK$5.49 B96.85%
2000HK$2.78 B-12.26%
1999HK$3.17 B

End of Day market cap according to different sources

On May 1st, 2026 the market cap of BioMarin Pharmaceutical was reported to be:

HK$81.85 Billion
by Nasdaq info icon info icon
HK$81.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
HK$864.90 B 956.65%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
HK$19.07 B-76.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.43 B-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
HK$6.27 B-92.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
HK$35.64 B-56.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
HK$27.49 B-66.41%๐Ÿ‡บ๐Ÿ‡ธ USA